Literature DB >> 26596802

Understanding Heart Failure.

Jeremy A Mazurek1, Mariell Jessup2.   

Abstract

Heart failure (HF) is a growing global health concern that affects more than 20 million people worldwide. With an ever-growing segment of the population over the age of 65, the prevalence of HF and its associated costs are expected to increase exponentially over the next decade. Advances in the understanding of the pathophysiology and treatment of HF have resulted in the ability to enhance both the quantity and the quality of life of patients with HF. This article reviews the current understanding of the pathophysiology, cause, classification, and treatment of HF and describes areas of uncertainty that demand future study.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ACE inhibitors; Ejection fraction; HFrEF; Heart failure; Neurohormonal blockade; Treatment; β-Blockers

Mesh:

Substances:

Year:  2015        PMID: 26596802     DOI: 10.1016/j.ccep.2015.08.001

Source DB:  PubMed          Journal:  Card Electrophysiol Clin        ISSN: 1877-9182


  5 in total

1.  Cardiospecific deletion of αE-catenin leads to heart failure and lethality in mice.

Authors:  Volodymyr V Balatskyi; Larysa L Macewicz; Ana-Maria Gan; Sergii V Goncharov; Paulina Pawelec; Georgiy V Portnichenko; Tetiana Yu Lapikova-Bryginska; Viktor O Navrulin; Victor E Dosenko; Adam Olichwier; Pawel Dobrzyn; Oksana O Piven
Journal:  Pflugers Arch       Date:  2018-06-20       Impact factor: 3.657

Review 2.  Role of the Pharmacist for Improving Self-care and Outcomes in Heart Failure.

Authors:  Daya Ram Parajuli; Julie Franzon; Ross A McKinnon; Sepehr Shakib; Robyn A Clark
Journal:  Curr Heart Fail Rep       Date:  2017-04

3.  Sacubitril/valsartan in everyday clinical practice: an observational study based on the experience of a heart failure clinic.

Authors:  Joana Cabral; Henrique Vasconcelos; Paulo Maia-Araújo; Emília Moreira; Manuel Campelo; Sandra Amorim; Alexandra Sousa; Brenda Moura; Roberto Pinto; Camila Dias; José Silva-Cardoso
Journal:  Cardiovasc Diagn Ther       Date:  2021-12

4.  Ivabradine for coronary artery disease and/or heart failure-a protocol for a systematic review of randomised clinical trials with meta-analysis and Trial Sequential Analysis.

Authors:  M Maagaard; E E Nielsen; C Gluud; J C Jakobsen
Journal:  Syst Rev       Date:  2019-02-01

5.  The effects of adding angiotensin receptor neprilysin inhibitors to usual care in patients with heart failure: a protocol for a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis.

Authors:  Emil Eik Nielsen; Joshua Feinberg; Ilan Raymond; Michael Hecht Olsen; Frank Victor Steensgaard-Hansen; Janus Christian Jakobsen
Journal:  Syst Rev       Date:  2019-10-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.